RT Journal Article
SR Electronic
A1 Canavan, Neil
T1 Predictive Biomarkers for Response to Cetuximab in Colorectal Cancer: KRAS Marches On
JF MD Conference Express
YR 2008
FD SAGE Publications
VO 8
IS 4
SP 4
OP 5
DO 10.1177/155989770800800401
UL http://mdc.sagepub.com/content/8/4/4.abstract
AB In the parade of molecules that strives for validation as predictors of therapeutic activity, the oncogene KRAS seems to have found its place in front of the band. This article discusses two studies that examined the utility of this marker in predicting response to cetuximab.